335 related articles for article (PubMed ID: 11371621)
1. Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation.
Pendino F; Flexor M; Delhommeau F; Buet D; Lanotte M; Segal-Bendirdjian E
Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6662-7. PubMed ID: 11371621
[TBL] [Abstract][Full Text] [Related]
2. A novel mechanism of retinoic acid resistance in acute promyelocytic leukemia cells through a defective pathway in telomerase regulation.
Pendino F; Sahraoui T; Lanotte M; Ségal-Bendirdjian E
Leukemia; 2002 May; 16(5):826-32. PubMed ID: 11986943
[TBL] [Abstract][Full Text] [Related]
3. Telomerase targeting by retinoids in cells from patients with myeloid leukemias of various subtypes, not only APL.
Pendino F; Hillion J; Dudognon C; Delaunay J; Mourah S; Podgorniak MP; Lafon I; Chomienne C; Lanotte M; Dombret H; Rousselot P; Ségal-Bendirdjian E
Leukemia; 2006 Apr; 20(4):599-603. PubMed ID: 16482212
[TBL] [Abstract][Full Text] [Related]
4. Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization.
Nason-Burchenal K; Maerz W; Albanell J; Allopenna J; Martin P; Moore MA; Dmitrovsky E
Differentiation; 1997 Aug; 61(5):321-31. PubMed ID: 9342843
[TBL] [Abstract][Full Text] [Related]
5. Synergistic down-regulation of telomerase activity and hTERT mRNA expression by combination of retinoic acid and GM-CSF in human myeloblastic leukemia ML-1 cells.
Mano Y; Shimizu T; Tanuma S; Takeda K
Anticancer Res; 2000; 20(3A):1649-52. PubMed ID: 10928085
[TBL] [Abstract][Full Text] [Related]
6. Retinoic acid receptor alpha and retinoid-X receptor-specific agonists synergistically target telomerase expression and induce tumor cell death.
Pendino F; Dudognon C; Delhommeau F; Sahraoui T; Flexor M; Bennaceur-Griscelli A; Lanotte M; Ségal-Bendirdjian E
Oncogene; 2003 Dec; 22(57):9142-50. PubMed ID: 14668795
[TBL] [Abstract][Full Text] [Related]
7. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
[TBL] [Abstract][Full Text] [Related]
8. Retinoic acid inhibits telomerase activity and downregulates expression but does not affect splicing of hTERT: correlation with cell growth rate inhibition in an in vitro cervical carcinogenesis/multidrug-resistance model.
Ding Z; Green AG; Yang X; Chernenko G; Tang SC; Pater A
Exp Cell Res; 2002 Jan; 272(2):185-91. PubMed ID: 11777343
[TBL] [Abstract][Full Text] [Related]
9. Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines.
Albanell J; Han W; Mellado B; Gunawardane R; Scher HI; Dmitrovsky E; Moore MA
Cancer Res; 1996 Apr; 56(7):1503-8. PubMed ID: 8603393
[TBL] [Abstract][Full Text] [Related]
10. The expression of telomeric proteins and their probable regulation of telomerase during the differentiation of all-trans-retinoic acid-responsive and -resistant acute promyelocytic leukemia cells.
Sun J; Huang H; Zhu Y; Lan J; Li J; Lai X; Yu J
Int J Hematol; 2005 Oct; 82(3):215-23. PubMed ID: 16207594
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of poly(ADP-ribose) polymerase promotes cell cycle arrest and inhibits neutrophilic differentiation of NB4 acute promyelocytic leukemia cells.
Bhatia M; Kirkland JB; Meckling-Gill KA
Cell Growth Differ; 1996 Jan; 7(1):91-100. PubMed ID: 8788037
[TBL] [Abstract][Full Text] [Related]
12. Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity.
Ducrest AL; Amacker M; Mathieu YD; Cuthbert AP; Trott DA; Newbold RF; Nabholz M; Lingner J
Cancer Res; 2001 Oct; 61(20):7594-602. PubMed ID: 11606399
[TBL] [Abstract][Full Text] [Related]
13. Changes in telomerase activity, expression and splicing in response to differentiation of normal and carcinoma colon cells.
Fajkus J; Borsky M; Kunická Z; Kovaríková M; Dvoráková D; Hofmanová J; Kozubík A
Anticancer Res; 2003; 23(2B):1605-12. PubMed ID: 12820429
[TBL] [Abstract][Full Text] [Related]
14. Death receptor signaling regulatory function for telomerase: hTERT abolishes TRAIL-induced apoptosis, independently of telomere maintenance.
Dudognon C; Pendino F; Hillion J; Saumet A; Lanotte M; Ségal-Bendirdjian E
Oncogene; 2004 Sep; 23(45):7469-74. PubMed ID: 15326479
[TBL] [Abstract][Full Text] [Related]
15. Suppression of telomerase reverse transcriptase (hTERT) expression in differentiated HL-60 cells: regulatory mechanisms.
Xu D; Gruber A; Björkholm M; Peterson C; Pisa P
Br J Cancer; 1999 Jun; 80(8):1156-61. PubMed ID: 10376966
[TBL] [Abstract][Full Text] [Related]
16. Amplification of hTERT and hTERC genes in leukemic cells with high expression and activity of telomerase.
Nowak T; Januszkiewicz D; Zawada M; Pernak M; Lewandowski K; Rembowska J; Nowicka K; Mankowski P; Nowak J
Oncol Rep; 2006 Aug; 16(2):301-5. PubMed ID: 16820907
[TBL] [Abstract][Full Text] [Related]
17. Distinct apoptotic responses in maturation sensitive and resistant t(15;17) acute promyelocytic leukemia NB4 cells. 9-cis retinoic acid induces apoptosis independent of maturation and Bcl-2 expression.
Bruel A; Benoit G; De Nay D; Brown S; Lanotte M
Leukemia; 1995 Jul; 9(7):1173-84. PubMed ID: 7630193
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of full-length telomerase reverse transcriptase mRNA and telomerase activity between normal and malignant renal tissues.
Fan Y; Liu Z; Fang X; Ge Z; Ge N; Jia Y; Sun P; Lou F; Björkholm M; Gruber A; Ekman P; Xu D
Clin Cancer Res; 2005 Jun; 11(12):4331-7. PubMed ID: 15958614
[TBL] [Abstract][Full Text] [Related]
19. Effect of all-trans retinoic acid and arsenic trioxide on tissue factor expression in acute promyelocytic leukemia cells.
Guo W; Wang H; Zhao W; Zhu J; Ju B; Wang X
Chin Med J (Engl); 2001 Jan; 114(1):30-4. PubMed ID: 11779431
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic plasticity of hTERT gene promoter determines retinoid capacity to repress telomerase in maturation-resistant acute promyelocytic leukemia cells.
Azouz A; Wu YL; Hillion J; Tarkanyi I; Karniguian A; Aradi J; Lanotte M; Chen GQ; Chehna M; Ségal-Bendirdjian E
Leukemia; 2010 Mar; 24(3):613-22. PubMed ID: 20072159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
